Business Context and Reporting Period
Company: Phibro Animal Health Corporation (PAHC)
Filing Type: Form 8-K (Current Report)
Date of Report: February 4, 2026
Reporting Period: Fiscal quarter ended December 31, 2025
This filing serves as a notification that the company issued a press release on February 4, 2026, announcing operating results for the quarter ended December 31, 2025, and providing financial guidance for the fiscal year ending June 30, 2026.
Key Financial Metrics
The provided text is a cover page and index for the Form 8-K. It references a press release (Exhibit 99.1) containing the specific data but does not list the numerical values within this document.
- Revenue, Profit, Cash Flow, Margins: Not provided in this text; contained in the referenced press release.
- Debt and Liquidity: Not provided in this text; contained in the referenced press release.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms that such results were announced in the attached press release.
Guidance, Outlook, and Risks
- Guidance: The company issued financial guidance for the fiscal year ending June 30, 2026, as part of the February 4, 2026 press release.
- Management Commentary: Referenced in the press release (Exhibit 99.1) but not detailed in this filing text.
- Risks and Contingencies: No specific risks or contingencies are detailed in this text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 4, 2026) for actual revenue, earnings, and cash flow figures for the quarter ended December 31, 2025.
- Verify the specific full-year 2026 guidance numbers and assumptions provided in the press release.
- Confirm whether the guidance includes any adjustments for unusual items or one-time costs.
- Check the press release for any updates on liquidity positions or debt covenants not explicitly stated in this 8-K summary.